Related Experiment Videos
[Study methods of drugs in Alzheimer disease]
B Dubois1, B Stehlé, J P Lehner
1Fédération de Neurologie, Hôpital Salpêtrière 47 Bd de l'hôpital, Paris, France.
Therapie
|July 1, 1996
Abstract:
The availability of new drugs for Alzheimer's disease, with different pharmacological profiles, leads to a redefinition the relevant methodology for developing drugs in this indication, including the inclusion/exclusion criteria, the duration of the studies, and therefore, the relevant guidelines. This was the purpose of the Giens Round-table devoted to the new methodology for drug development in Alzheimer disease.